Skip to content

Penumbra PEN Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

Arthur J. Gallagher logo
Arthur J. GallagherAJG
$11M
BorgWarner logo
BorgWarnerBWA
$2.11B+23.6%
BK
BKBK
$4.4B+15.8%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$1.17B-92.9%
Insulet logo
InsuletPODD
$480.4M-62.6%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$2.29B-7.6%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's cash, cash equivalents, and marketable securities?
Penumbra (PEN) reported cash, cash equivalents, and marketable securities of $342.66M in Q1 2026.
How has Penumbra's cash, cash equivalents, and marketable securities changed year-over-year?
Penumbra's cash, cash equivalents, and marketable securities increased by 12164.3% year-over-year, from $2.79M to $342.66M.
What is the long-term trend for Penumbra's cash, cash equivalents, and marketable securities?
Over 5 years (2020 to 2025), Penumbra's cash, cash equivalents, and marketable securities has grown at a 44.5% compound annual growth rate (CAGR), from $13.96M to $88.07M.